70.40
price up icon0.30%   0.21
after-market Dopo l'orario di chiusura: 70.50 0.10 +0.14%
loading

Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
23.67%
194.43
157.21 181.89 182.55 163.80
Cost Of Revenue
42.86%
3.433
2.403 2.956 2.867 2.524
Gross Profit
23.37%
191.00
154.81 178.93 179.68 161.27
Operating Expenses
8.54%
164.32
151.40 153.67 133.08 125.68
Benefits Costs and Expenses
10.26%
162.74
147.60 149.93 129.60 122.20
Costs And Expenses
9.07%
167.75
153.80 156.63 135.95 128.20
Operating Income/Loss
680.88%
26.68
3.416 25.26 46.60 35.59
Nonoperating Income/Loss
19.11%
5.017
6.202 6.698 6.345 6.004
Income/Loss From Continuing Operations Before Tax
229.51%
31.69
9.618 31.96 52.94 41.60
Income Tax Expense/Benefit, Deferred
29.62%
-17.76
-13.71 -3.858 -15.21 -13.96
Income Tax Expense/Benefit
68.37%
-3.457
-10.93 1.214 5.73 6.108
Income/Loss From Continuing Operations After Tax
71.07%
35.15
20.55 30.75 47.21 35.49
Net Income/Loss
71.07%
35.15
20.55 30.75 47.21 35.49
Preferred Stock Dividends And Other Adjustments
0.538
- 0.357 0.523 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
104.11
104.11 0.138 103.37 103.12
Diluted Average Shares
0.56%
120.48
119.82 1.909 113.72 111.24
Basic Earnings Per Share
73.68%
0.33
0.19 0.29 0.45 0.34
Diluted Earnings Per Share
70.59%
0.29
0.17 0.25 0.41 0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.538
- 0.357 0.523 -
$36.88
price up icon 2.44%
$86.20
price up icon 0.87%
$25.87
price up icon 2.05%
$111.30
price down icon 0.09%
$129.45
price up icon 1.76%
biotechnology ONC
$309.33
price down icon 1.02%
Capitalizzazione:     |  Volume (24 ore):